Gretta Blatner

914 total citations
14 papers, 203 citations indexed

About

Gretta Blatner is a scholar working on Oncology, Immunology and Infectious Diseases. According to data from OpenAlex, Gretta Blatner has authored 14 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Gretta Blatner's work include Immunodeficiency and Autoimmune Disorders (3 papers), Immune responses and vaccinations (3 papers) and Cancer Treatment and Pharmacology (3 papers). Gretta Blatner is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (3 papers), Immune responses and vaccinations (3 papers) and Cancer Treatment and Pharmacology (3 papers). Gretta Blatner collaborates with scholars based in United States, Netherlands and Kenya. Gretta Blatner's co-authors include Bruce D. Cheson, John Wright, Cheson Bd, Marcia Irene Canto, Amitabh Chak, Neil Senzer, John Nemunaitis, Alexander Rosemurgy, Richard A. Erickson and Mitchell C. Posner and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Gretta Blatner

14 papers receiving 192 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gretta Blatner United States	8	115	65	48	41	39	14	203
Alisha Arora United States	9	184 1.6×	77 1.2×	85 1.8×	28 0.7×	38 1.0×	12	314
Y. Yamashita Japan	10	122 1.1×	108 1.7×	52 1.1×	127 3.1×	45 1.2×	28	386
Tomiya Masuno Japan	12	103 0.9×	88 1.4×	60 1.3×	56 1.4×	36 0.9×	35	346
Rebekah Engel Australia	6	104 0.9×	58 0.9×	16 0.3×	24 0.6×	27 0.7×	12	206
Hong Liao China	9	69 0.6×	107 1.6×	45 0.9×	42 1.0×	21 0.5×	21	352
Tania B. Porras United States	9	139 1.2×	93 1.4×	67 1.4×	36 0.9×	21 0.5×	16	300
Rocío Lavado-Valenzuela Spain	8	85 0.7×	190 2.9×	33 0.7×	27 0.7×	22 0.6×	16	333
Ramya Krishnan Canada	8	97 0.8×	83 1.3×	32 0.7×	12 0.3×	31 0.8×	18	256
Koichi Kubota Japan	10	72 0.6×	78 1.2×	91 1.9×	48 1.2×	52 1.3×	54	333
Kwok-Wah Chan Hong Kong	7	62 0.5×	150 2.3×	25 0.5×	33 0.8×	63 1.6×	9	287

Countries citing papers authored by Gretta Blatner

Since Specialization

Citations

This map shows the geographic impact of Gretta Blatner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gretta Blatner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gretta Blatner more than expected).

Fields of papers citing papers by Gretta Blatner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gretta Blatner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gretta Blatner. The network helps show where Gretta Blatner may publish in the future.

Co-authorship network of co-authors of Gretta Blatner

This figure shows the co-authorship network connecting the top 25 collaborators of Gretta Blatner. A scholar is included among the top collaborators of Gretta Blatner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gretta Blatner. Gretta Blatner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Sivakumaran, Dhanasekaran, Gretta Blatner, David A. Hokey, et al.. (2021). A 2-Dose AERAS-402 Regimen Boosts CD8+ Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients. Frontiers in Immunology. 12. 673532–673532. 10 indexed citations

Wolfe, Daniel, Eric M. Espeland, Yonghong Gao, et al.. (2020). Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older. Vaccine. 38(50). 7970–7976. 8 indexed citations

Nduba, Videlis, Samuel Gurrion Ouma, Gretta Blatner, et al.. (2020). Development of a TB vaccine trial site in Africa and lessons from the Ebola experience. BMC Public Health. 20(1). 999–999. 2 indexed citations

Arlehamn, Cecilia S. Lindestam, Richard Copin, Shay Leary, et al.. (2017). Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 100 Luo infants from the Boro area of Nyanza Province, Kenya. Human Immunology. 78(4). 325–326. 5 indexed citations

Nyendak, Melissa, Gwendolyn Swarbrick, Meghan Cansler, et al.. (2016). Adenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 Vaccine. Scientific Reports. 6(1). 36355–36355. 25 indexed citations

Hokey, David A., Michèle Tameris, Veerabadran Dheenadhayalan, et al.. (2015). Safety and immunogenicity of the Ad35/AERAS-402 tuberculosis vaccine in a phase 2 dose-finding clinical trial in BCG-vaccinated healthy infants (VAC5P.1119). The Journal of Immunology. 194(1_Supplement). 73.4–73.4. 2 indexed citations

Hecht, J. Randolph, Neil Senzer, John Nemunaitis, et al.. (2012). EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointestinal Endoscopy. 75(2). 332–338. 92 indexed citations

Chang, Kenneth J., Reiko Ashida, M. Raman, et al.. (2009). Overall Survival in Locally Advanced Pancreatic Cancer Patients Treated with a Biologic Using Endoscopic Ultrasound (EUS) FNI or CT-Guided Injection: A Single Institution Experience. Gastrointestinal Endoscopy. 69(5). AB132–AB133. 4 indexed citations

Blatner, Gretta, et al.. (1999). Clinical trials referral resource. Clinical trials with gadolinium-texaphyrin and lutetium-texaphyrin.. PubMed. 13(5). 671, 674–6. 3 indexed citations

10.

Wright, James R., Gretta Blatner, & Bruce D. Cheson. (1999). Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777.. PubMed. 13(11). 1527, 1530, 1533–1527, 1530, 1533. 10 indexed citations

11.

Blatner, Gretta, et al.. (1999). Clinical trials referral resource. Clinical trials of dolastatin-10.. PubMed. 13(1). 68–70, 75. 8 indexed citations

12.

Murgo, Antonella, et al.. (1999). Clinical trials referral resource. Clinical trials of MGI-114.. PubMed. 13(2). 233, 237–8. 8 indexed citations

13.

Blatner, Gretta, et al.. (1999). Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin.. PubMed. 13(8). 1116–8. 2 indexed citations

14.

Wright, John, Gretta Blatner, & Bruce D. Cheson. (1998). Clinical trials referral resource. Clinical trials of flavopiridol.. PubMed. 12(7). 1018, 1023–4. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact